Homepage
Medication Guide
Recommended Dosage of Emicizumab
Emicizumab is a subcutaneous injection preparation indicated for routine prophylactic treatment in adult and pediatric patients. Treatment usually starts with a loading dose, followed by a maintenance...
503
Friday, September 5th, 2025, 13:49
Indications of Natalizumab
Natalizumab is a recombinant humanized IgG4κ monoclonal antibody, with the brand name TYSABRI®. This article will systematically introduce the drug's indications, dosage and administration, and pr...
501
Thursday, September 4th, 2025, 17:11
Side Effects and Countermeasures
Natalizumab (brand name: TYSABRI®) is a recombinant humanized IgG4κ monoclonal antibody. It blocks the migration of immune cells by inhibiting α4-integrin and is used in the treatment of relapsing mul...
503
Thursday, September 4th, 2025, 17:06
How to Use Natalizumab
Natalizumab is a humanized monoclonal antibody used in the treatment of relapsing forms of multiple sclerosis (MS). It works by inhibiting the migration of leukocytes into the central nervous system, ...
502
Thursday, September 4th, 2025, 17:03
What Diseases Does Natalizumab Treat?
Natalizumab (brand name: TYSABRI®) is a humanized monoclonal antibody primarily used in the treatment of specific neurological disorders. Based on the content of the FDA label, this article systematic...
502
Thursday, September 4th, 2025, 16:59
What is Pemazyre (Pemigatinib)?
Pemazyre (pemigatinib) is a targeted therapy drug approved for marketing by the U.S. FDA in 2020. It belongs to the class of kinase inhibitors and is mainly used for the treatment of specific types of...
502
Thursday, September 4th, 2025, 16:57
Precautions for the Use of Pemazyre (Pemigatinib)
Pemazyre (pemigatinib) is a kinase inhibitor that targets FGFR1/2/3. It inhibits tumor growth by blocking abnormal FGFR signaling pathways, but its use must strictly adhere to medication guidelines.Pr...
503
Thursday, September 4th, 2025, 16:53
How to Use Pemazyre (Pemigatinib)
Pemazyre (pemigatinib) is a kinase inhibitor indicated for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma, and the presence of ...
503
Thursday, September 4th, 2025, 16:51
How Effective is Pemazyre (Pemigatinib) Treatment?
Pemazyre (pemigatinib) is a targeted therapeutic drug indicated for patients with specific types of cholangiocarcinoma. As a FGFR1/2/3 kinase inhibitor, it inhibits tumor growth by blocking abnormally...
501
Thursday, September 4th, 2025, 16:48
What Are the Side Effects of Pemazyre (Pemigatinib)?
Pemazyre (pemigatinib) is a targeted drug used for the treatment of specific types of cholangiocarcinoma. It exerts its therapeutic effect by inhibiting the abnormal activation of the FGFR2 gene. Desp...
501
Thursday, September 4th, 2025, 16:44
106 / 186
1852 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved